“The mission of healthcare is to improve people’s quality of life so, if a pharmaceutical company has products or practices that are leading to climate change, it’s absolutely contradictory,” argues Maria Paola Chiesi, chair of the board for global biopharmaceutical company, Chiesi.
The climate crisis is also a health crisis, she says, pointing to research by the University of Michigan Medical School, which shows that pollution has consequences not just for lung health but also for cardiovascular and brain health.
